Clinical Trials Logo
  1. Home
  2. Hemorrhage
  3. NCT04651166
  4. Details
NCT04651166 Clinical Trial

Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation

Hemorrhage Clinical Trial

Official title:
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04651166
Other study ID # RA-2020-050
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date February 15, 2022
Est. completion date July 27, 2023

Study information
Verified date August 2023
Source University of Hawaii
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prophylactic tranexamic acid has shown been shown to reduce maternal mortality from postpartum hemorrhage with no adverse effects, but has not been studied to reduce bleeding complications with dilation and evacuation (D&E). We propose a randomized, double-blinded, placebo-controlled pilot study to determine whether routine use of intravenous (IV) tranexamic acid will decrease the need for interventions to control bleeding at the time of D&E at 16 to 24 weeks gestation.

Recruitment information / eligibility
Status Completed
Enrollment 48
Est. completion date July 27, 2023
Est. primary completion date July 27, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 14 Years and older
Eligibility Inclusion Criteria: - Requesting pregnancy termination - Intrauterine pregnancy at 16 to 24 weeks gestation - Participants must be willing and capable of giving informed consent and able to understand and sign written consents in English. Exclusion Criteria: - History of thromboembolic events (i.e. deep vein thrombosis, stroke, pulmonary embolism)

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Tranexamic acid
1g tranexamic acid mixed in 100mL saline or lactated ringer
• Placebo
100mL saline or lactated ringers

Locations
Country Name City State
United States Queens Medical Center Honolulu Hawaii

Sponsors (2)
Lead Sponsor Collaborator
University of Hawaii Society of Family Planning

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Intervention to control blood loss Rate at which providers perform interventions to control blood loss during D&E procedures At time of procedure
See also
  Status Clinical Trial Phase
Completed NCT02815670 - Reversal Dabigatran Anticoagulant Effect With Idarucizumab Phase 3
Completed NCT04588350 - Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery N/A
Recruiting NCT02972385 - Pharmacogenomics of Warfarin in Hispanics and Latinos
Completed NCT02569606 - Transfusion and Coagulation Management in Trauma Patients After the Introduction of a Coagulation Algorithm
Completed NCT02554006 - Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings N/A
Recruiting NCT02446730 - Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Phase 4
Completed NCT01955720 - Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran Phase 1
Completed NCT01935427 - Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume N/A
Recruiting NCT01709786 - Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage N/A
Completed NCT01210417 - Trauma Heart to Arm Time N/A
Completed NCT01136590 - Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery Phase 4
Completed NCT01191554 - Dose-ranging Study of Tranexamic Acid in Valve Surgery N/A
Completed NCT01085006 - The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery Phase 1/Phase 2
Completed NCT00700141 - Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil® N/A
Completed NCT00375466 - Tranexamic Acid, Hemorrhage and Transfusions After Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery. N/A
Completed NCT00479362 - Anticoagulant Therapy During Pacemaker Implantation Phase 4
Completed NCT00147420 - RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet N/A
Recruiting NCT05945680 - Tranexamic Acid in Breast Esthetic Surgery. Phase 4
Completed NCT03273322 - Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure Phase 2/Phase 3
Withdrawn NCT05672407 - The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery Phase 4